The store will not work correctly when cookies are disabled.
6-chloro-3-(1-phenylcyclopropyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine1,1-dioxide
ID: ALA379292
PubChem CID: 135428234
Max Phase: Preclinical
Molecular Formula: C14H12ClN3O2S2
Molecular Weight: 353.86
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S1(=O)NC(NC2(c3ccccc3)CC2)=Nc2cc(Cl)sc21
Standard InChI: InChI=1S/C14H12ClN3O2S2/c15-11-8-10-12(21-11)22(19,20)18-13(16-10)17-14(6-7-14)9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H2,16,17,18)
Standard InChI Key: NSHQOOIHPDLZQY-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
0.6171 -25.1302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4387 -25.1302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0279 -24.4169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1167 -25.6452 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.4035 -25.2385 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4035 -24.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1167 -23.9936 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6154 -25.4911 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.8300 -25.2385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8300 -24.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6162 -24.1560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0969 -24.8264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5353 -26.2303 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7055 -26.2303 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3134 -23.9998 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9228 -24.8285 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.7449 -24.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4561 -24.4247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1683 -24.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1712 -23.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4559 -22.7730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7424 -23.1834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 9 1 0
10 11 1 0
11 12 2 0
12 8 1 0
9 4 1 0
4 13 2 0
4 5 1 0
4 14 2 0
5 6 1 0
6 15 1 0
6 7 2 0
12 16 1 0
15 3 1 0
9 10 2 0
3 17 1 0
1 3 1 0
17 18 2 0
18 19 1 0
2 1 1 0
19 20 2 0
3 2 1 0
20 21 1 0
10 7 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 353.86 | Molecular Weight (Monoisotopic): 353.0059 | AlogP: 2.96 | #Rotatable Bonds: 2 |
Polar Surface Area: 70.56 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.48 | CX Basic pKa: 1.42 | CX LogP: 3.36 | CX LogD: 2.46 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.87 | Np Likeness Score: -0.96 |
References
1. Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB.. (2006) New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells., 49 (14): [PMID:16821773] [10.1021/jm060042j] |